首页|期刊导航|Genes & Diseases|First-trimester preeclampsia prediction model via integrative machine learning of maternal risk profiles and laboratory markers

First-trimester preeclampsia prediction model via integrative machine learning of maternal risk profiles and laboratory markersOA

中文摘要

Preeclampsia(PE)affects 2%—8%of pregnancies worldwide and remains a major cause of maternal and perinatal complications.Early risk identification is essential,yet current models,such as those from the Fetal Medicine Foundation(FMF),show limited sensitivity,especially for term PE.We investigated whether first-trimester routine laboratory markers could enhance PE prediction in a retrospective cohort of 12,715 pregnancies,including 556(4.4%)PE cases.Elevated gamma-glutamyltransferase(GGT),C-reactive protein(CRP),triglyc-eride-glucose index multiple of the median(TyG MoM),and uric acid-to-albumin ratio multiple of the median(UAR MoM)were independently associated with a higher risk of PE,whereas magnesium,iron,and high-density lipoprotein cholesterol were inversely associated with the condition.Several markers also exhibited nonlinear and threshold effects.These features were incorporated into machine learning frameworks,with distinct models for preterm and term PE.For preterm PE,the CatBoost model achieved an AUC of 0.954 and detected 92.5% of cases at a 14% false-positive rate when integrated with the FMF model,compared with 65% detection with FMF alone.For term PE,logistic regression yielded an AUC of 0.913 and 81.1% detection,substantially outperforming FMF sensitivity(47.7%).Parallel cell-free DNA transcriptomic profiling revealed early metabolic and inflammatory dysregulation,and GEO da-taset analyses provided external validation,supporting laboratory findings.These results indi-cate that the incorporation of accessible laboratory markers into existing clinical frameworks,combined with machine learning,provides a cost-effective and scalable strategy for enhanced PE risk stratification and precision management.

Yi Zhu;Yanqiu Zhang;Chao Huang;Sheng Zhang;Jun Cao;Nicole Miranda;Sarina Zhao;Yan Peng;Chao Yu;Bin Feng;Jieyu Jin;Qingqin Tang;Jiaming Fan;Longwei Qiao;Yuting Liang

Department of Orthopaedic Surgery,The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu 215031,China Institute of Orthopaedics,Soochow University,Suzhou,Jiangsu 215000,China Molecular Oncology Laboratory,Department of Orthopedic Surgery and Rehabilitation Medicine,The University of Chicago Medical Center,Chicago,IL 60637,USAInstitute of Clinical Pharmacology,School of Pharmacy,Anhui Medical University,Key Laboratory of Anti-inflammatory and Immune Medicine(Anhui Medical University),Ministry of Education,Hefei,Anhui 230032,ChinaCenter for Reproduction and Genetics,School of Gusu,The Affiliated Suzhou Hospital of Nanjing Medical University,Suzhou Municipal Hospital,Nanjing Medical University,Suzhou,Jiangsu 215002,ChinaCenter for Clinical Laboratory,The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu 215031,ChinaCenter for Clinical Laboratory,The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu 215031,ChinaMolecular Oncology Laboratory,Department of Orthopedic Surgery and Rehabilitation Medicine,The University of Chicago Medical Center,Chicago,IL 60637,USAMolecular Oncology Laboratory,Department of Orthopedic Surgery and Rehabilitation Medicine,The University of Chicago Medical Center,Chicago,IL 60637,USAMolecular Oncology Laboratory,Department of Orthopedic Surgery and Rehabilitation Medicine,The University of Chicago Medical Center,Chicago,IL 60637,USA Departments of Orthopaedic Surgery,Cardiology,and Obstetrics and Gynecology,The Affiliated University-town Hospital,Chongqing Medical University,Chongqing 401331,ChinaMolecular Oncology Laboratory,Department of Orthopedic Surgery and Rehabilitation Medicine,The University of Chicago Medical Center,Chicago,IL 60637,USA Departments of Orthopaedic Surgery,Cardiology,and Obstetrics and Gynecology,The Affiliated University-town Hospital,Chongqing Medical University,Chongqing 401331,ChinaCenter for Clinical Laboratory,The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu 215031,ChinaCenter for Clinical Laboratory,The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu 215031,ChinaCenter for Clinical Laboratory,The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu 215031,ChinaMolecular Oncology Laboratory,Department of Orthopedic Surgery and Rehabilitation Medicine,The University of Chicago Medical Center,Chicago,IL 60637,USA Ministry of Education Key Laboratory of Diagnostic Medicine,Department of Clinical Biochemistry,School of Laboratory Diagnostic Medicine,Chongqing Medical University,Chongqing 400016,ChinaCenter for Reproduction and Genetics,School of Gusu,The Affiliated Suzhou Hospital of Nanjing Medical University,Suzhou Municipal Hospital,Nanjing Medical University,Suzhou,Jiangsu 215002,China State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai 200438,ChinaCenter for Clinical Laboratory,The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu 215031,China Molecular Oncology Laboratory,Department of Orthopedic Surgery and Rehabilitation Medicine,The University of Chicago Medical Center,Chicago,IL 60637,USA

医药卫生

FMF prediction modelLaboratory markersMachine learningPreeclampsiaTriglyceride-glucose index

《Genes & Diseases》 2026 (6)

P.642-659,18

supported by the Science Foundation of Jiangsu Province(China)(No.BK20240371)the Suzhou Health Talent Program(Jiangsu,China)(No.GSWS2024046)the National Key R&D Program of China(No.2023YFC2705600,2023YFC2705602)the National Natural Science Foundation of China(No.82001576)the Postdoctoral Fellowship Program of CPSF(No.GZC20251571)the Jiangsu Funding Program for Excellent Postdoctoral Talent(China)(No.2025ZB269)Suzhou Science and Technology Support Program(China)(No.SKY2023001,SYW2025137)the Primary Research and Development Plan of Jiangsu Province,China(No.BE2022736)the Jiangsu Province College Students’Innovation and Entrepreneurship Training Program Project(China)(No.202410285273Y).

10.1016/j.gendis.2026.102075

评论